2026 ASCO Breast Cancer Highlights: persevERA - Poll - MDSpire

2026 ASCO Breast Cancer Highlights: persevERA

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the persevERA trial and oral SERDS in metastatic breast cancer.

October 15, 2026

Dana-Farber

Share

Original Source(s)

Dana-Farber

2026 ASCO Breast Cancer Highlights: persevERA

October 15, 2026

Related Content

Int. Journal Of Computer Assisted Radiology And Surgery

Resection zone prediction for parenchyma-sparing hepatectomy planning: a comparative study of three modeling paradigms

Jama Network Open

Outcomes for American Indian and Alaska Native Populations With Cancer in Traditional Medicare

by T. Anders Olsen, Matthew Tobey
October 7, 2026

European Radiology

Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI

by Eduardo Pooch, Georgios Agrotis, Ivo G. Schoots, Mark Emberton, Veeru Kasivisvanathan, Yipeng Hu
October 7, 2026